mAb-926 University of Washington/Fred Hutchinson Cancer Research Center/New York University School of Medicine

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamemAb-926 University of Washington/Fred Hutchinson Cancer Research Center/New York University School of Medicine
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEscherichia coli Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Washington
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew York University School Of MedicineUniversity Of WashingtonFred Hutchinson Cancer Research Center
Active IndicationsN/A
Inactive IndicationsEscherichia coli Infections

Other Information

ATC CodeN/A
Related LinksN/A